AzaSite® inhibits Staphylococcus aureus and coagulase-negative Staphylococcus biofilm formation in vitro.
Wu
Eric C
EC
UPMC Eye Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213, USA.
Kowalski
Regis P
RP
Romanowski
Eric G
EG
Mah
Francis S
FS
Gordon
Y Jerold
YJ
Shanks
Robert M Q
RM
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology*; D017963:Azithromycin / Q000008:administration & dosage / Q000494:pharmacology*; D001548:Benzalkonium Compounds / Q000494:pharmacology*; D018441:Biofilms / Q000187:drug effects*; D003030:Coagulase / Q000032:analysis; D004305:Dose-Response Relationship, Drug; D016503:Drug Delivery Systems; D024881:Drug Resistance, Bacterial; D009883:Ophthalmic Solutions; D011310:Preservatives, Pharmaceutical / Q000494:pharmacology; D013053:Spectrophotometry / Q000379:methods; D013210:Staphylococcus / Q000187:drug effects / Q000502:physiology; D013211:Staphylococcus aureus / Q000187:drug effects / Q000502:physiology
D000900:Anti-Bacterial Agents; D001548:Benzalkonium Compounds; D003030:Coagulase; D009883:Ophthalmic Solutions; D011310:Preservatives, Pharmaceutical; D017963:Azithromycin